Citadel Advisors - MAST THERAPEUTICS INC ownership

MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 39 filers reported holding MAST THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MAST THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$1,0000.0%12,000
-23.6%
0.00%
Q4 2016$1,000
-91.7%
15,700
-85.6%
0.00%
Q3 2016$12,000
-77.8%
109,300
-5.0%
0.00%
Q2 2016$54,000
+17.4%
115,070
+41.1%
0.00%
Q4 2014$46,000
+155.6%
81,561
+156.2%
0.00%
Q3 2014$18,000
+350.0%
31,837
+397.7%
0.00%
Q2 2014$4,000
-33.3%
6,397
-52.0%
0.00%
Q4 2013$6,000
-33.3%
13,325
-33.1%
0.00%
Q3 2013$9,000
-30.8%
19,925
-35.4%
0.00%
Q2 2013$13,00030,8530.00%
Other shareholders
MAST THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Corbenic Partners LLC 3,000$00.00%
View complete list of MAST THERAPEUTICS INC shareholders